Gail K. Naughton's most recent trade in TherapeuticsMD Inc was a trade of 8,500 Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 8,500 (0%) | 0% | 0 | Common Stock | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 8,500 | 0 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2023 | 8,500 | 8,500 | - | - | Restricted Stock Unit | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Sale of securities on an exchange or to another person at price $ 5.26 per share. | 07 Dec 2022 | 3,922 | 0 (0%) | 0% | 5.3 | 20,635 | Common Stock |
TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 0 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Aug 2022 | 1,984 | 3,922 (0%) | 0% | - | Common Stock | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 0 | - | - | Restricted Stock Units | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Aug 2021 | 96,864 | 96,864 (0%) | 0% | - | Common Stock | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 99,174 | 99,174 | - | - | Restricted Stock Units | |
Histogen Inc | Gail K. Naughton | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jan 2021 | 95,000 | 95,000 | - | - | Stock Option (right to buy) | |
TherapeuticsMD Inc | Gail K. Naughton | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2020 | 96,864 | 96,864 | - | - | Restricted Stock Units | |
Histogen Inc | Gail K. Naughton | See Remarks | Other type of transaction at price $ 0.00 per share. | 26 May 2020 | 426,526 | 426,526 | - | 0 | Common Stock | |
Histogen Inc | Gail K. Naughton | See Remarks | Other type of transaction at price $ 0.00 per share. | 26 May 2020 | 380,063 | 380,063 | - | - | Stock Option (right to buy) |